Vertex Pharmaceuticals (VRTX) EBIT Margin (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.00 |
| Dec 31, 2025 | -76.00 |
| Sep 30, 2025 | -27.00 |
| Jun 30, 2025 | 1,608.00 |
| Mar 31, 2025 | -1,249.00 |
| Dec 31, 2024 | -504.00 |
| Sep 30, 2024 | 17,312.00 |
| Jun 30, 2024 | -17,520.00 |
| Mar 31, 2024 | 309.00 |
| Dec 31, 2023 | -254.00 |
| Sep 30, 2023 | 63.00 |
| Jun 30, 2023 | 837.00 |
| Mar 31, 2023 | -1,208.00 |
| Dec 31, 2022 | -339.00 |
| Sep 30, 2022 | -211.00 |
| Jun 30, 2022 | 75.00 |
| Mar 31, 2022 | 728.00 |
| Dec 31, 2021 | -1,080.00 |
| Sep 30, 2021 | 5,526.00 |
| Jun 30, 2021 | -5,360.00 |
| Mar 31, 2021 | 567.00 |
| Dec 31, 2020 | 211.00 |
| Sep 30, 2020 | -340.00 |
| Jun 30, 2020 | -44.00 |
| Mar 31, 2020 | -30,642.00 |
| Dec 31, 2019 | 34,350.00 |
| Sep 30, 2019 | -1,822.00 |
| Jun 30, 2019 | -357.00 |
| Mar 31, 2019 | 1,757.00 |
| Dec 31, 2018 | -1,153.00 |
| Sep 30, 2018 | 323.00 |
| Jun 30, 2018 | 287.00 |
| Mar 31, 2018 | 82.00 |
| Dec 31, 2017 | 7,569.00 |
| Sep 30, 2017 | -6,608.00 |
| Jun 30, 2017 | -2,821.00 |
| Mar 31, 2017 | 2,925.00 |
| Dec 31, 2016 | 1,321.00 |
| Sep 30, 2016 | -536.00 |
| Jun 30, 2016 | 439.00 |
| Mar 31, 2016 | 961.00 |
| Dec 31, 2015 | 994.00 |
| Sep 30, 2015 | 7,992.00 |
| Jun 30, 2015 | 2,835.00 |
| Mar 31, 2015 | -2,514.00 |
| Dec 31, 2014 | -255.00 |
| Sep 30, 2014 | 4,388.00 |
| Jun 30, 2014 | 3,479.00 |
| Mar 31, 2014 | -17,441.00 |
| Dec 31, 2013 | 4,775.00 |
| Sep 30, 2013 | -3,727.00 |
| Jun 30, 2013 | 11,223.00 |
| Mar 31, 2013 | -10,749.00 |
| Dec 31, 2012 | -2,288.00 |
| Sep 30, 2012 | 226.00 |
| Jun 30, 2012 | -2,699.00 |
| Mar 31, 2012 | -1,533.00 |
| Dec 31, 2011 | -1,166.00 |
| Mar 31, 2011 | 3,724.00 |
| Dec 31, 2010 | 58,447.00 |
| Sep 30, 2010 | -30,253.00 |
| Jun 30, 2010 | 17,837.00 |
| Mar 31, 2010 | -28,168.00 |
| Dec 31, 2009 | 16,101.00 |
| Sep 30, 2009 | 23,046.00 |
| Jun 30, 2009 | -14,927.00 |